Credit Suisse Ag Neurocrine Biosciences Inc Transaction History

Credit Suisse Ag

$101 Billion
Q1 2024

Shares

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2022 Aug 12, 2022	SELL	N/A	-900,000 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	N/A	300,000 Added 50.0%	900,000 $1.11 Million
Q1 2021 May 14, 2021	BUY	N/A	300,000 Added 100.0%	600,000 $807,000
Q3 2020 Nov 13, 2020	SELL	N/A	-372,000 Reduced 55.36%	300,000 $413,000
Q2 2020 Aug 12, 2020	BUY	N/A	205,000 Added 43.9%	672,000 $1.12 Million
Q4 2019 Feb 12, 2020	SELL	N/A	-708,000 Reduced 60.26%	467,000 $715,000
Q3 2019 Nov 12, 2019	SELL	N/A	-500,000 Reduced 29.85%	1,175,000 $1.61 Million
Q2 2019 Aug 14, 2019	BUY	N/A	255,000 Added 17.96%	1,675,000 $2.2 Million
Q1 2019 May 14, 2019	BUY	N/A	1,120,000 Added 373.33%	1,420,000 $1.92 Million
Q4 2018 Feb 13, 2019	SELL	N/A	-500,000 Reduced 62.5%	300,000 $358,000
Q3 2018 Nov 13, 2018	SELL	N/A	-950,000 Reduced 54.29%	800,000 $1.36 Million
Q2 2018 Aug 14, 2018	BUY	N/A	1,750,000 New	1,750,000 $2.53 Million

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

News

Stay updated on Credit Suisse Ag with notifications on news.